PRO DEX INC Files Definitive Proxy Statement

Ticker: PDEX · Form: DEF 14A · Filed: Oct 8, 2024 · CIK: 788920

Pro Dex Inc DEF 14A Filing Summary
FieldDetail
CompanyPro Dex Inc (PDEX)
Form TypeDEF 14A
Filed DateOct 8, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$53M, $15M
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

PRO DEX INC proxy filed. Annual meeting Nov 21. Shareholders vote soon.

AI Summary

PRO DEX INC filed its definitive proxy statement on October 8, 2024, for its annual meeting on November 21, 2024. The company, previously known as PRO-DEX, INC., is headquartered in Irvine, CA, and operates in the Surgical & Medical Instruments & Apparatus industry. This filing is a standard procedural document for shareholder voting.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting, including any proposals to be voted on, which can impact the company's future direction and governance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) for a public company's annual meeting, not indicating any immediate financial distress or significant operational changes.

Key Numbers

  • 20241121 — Annual Meeting Date (Shareholders will vote on company matters.)
  • 20241008 — Filing Date (Date the definitive proxy statement was submitted to the SEC.)

Key Players & Entities

  • PRO DEX INC (company) — Registrant
  • PRO-DEX, INC. (company) — Former Company Name
  • CONTEXT CAPITAL FUNDS (company) — Former Company Name
  • 2361 MCGAW AVENUE (location) — Business and Mail Address
  • IRVINE (location) — City
  • CA (location) — State
  • 949-769-3231 (phone_number) — Business Phone

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit proxies from its shareholders for an upcoming shareholder meeting, providing detailed information about the matters to be voted upon.

When is PRO DEX INC's annual shareholder meeting scheduled?

PRO DEX INC's annual shareholder meeting is scheduled for November 21, 2024.

What industry does PRO DEX INC operate in?

PRO DEX INC operates in the Surgical & Medical Instruments & Apparatus industry, with SIC code 3841.

Has PRO DEX INC changed its name previously?

Yes, PRO DEX INC was formerly known as PRO-DEX, INC. and CONTEXT CAPITAL FUNDS, with name changes occurring on November 10, 2015, and July 3, 1992, respectively.

Where is PRO DEX INC headquartered?

PRO DEX INC is headquartered at 2361 McGaw Avenue, Irvine, CA 92614.

Filing Stats: 4,683 words · 19 min read · ~16 pages · Grade level 11.4 · Accepted 2024-10-08 16:00:17

Key Financial Figures

  • $53M — with another record for annual sales of $53M and our first $15M sales quarter. We ar
  • $15M — for annual sales of $53M and our first $15M sales quarter. We are proud of the fact

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL The following table sets forth information concerning the beneficial ownership of our Common Stock as of September 24, 2024 by: each member of the Board; each of our Named Executive Officers listed in the “Summary Compensation Table” included in the “Executive Compensation” section of this proxy statement; all of our directors and Named Executive Officers as a group; and each person or entity known to us that beneficially owns more than five percent of our Common Stock. Beneficial ownership is determined in accordance with the rules of the SEC. Unless otherwise indicated below, the address of each beneficial owner is c/o Pro-Dex, Inc., 2361 McGaw Avenue, Irvine, California, 92614. Unless otherwise indicated below, we believe that each of the persons listed in the table (subject to applicable community property laws) has the sole power to vote and to dispose of the shares listed opposite the shareholder’s name. The percentages of Common Stock beneficially owned are based on 3,322,854 shares of Common Stock outstanding at September 24, 2024. Number of Percent of Shares of Common Common Stock Stock Beneficially Beneficially Name and Address of Beneficial Owner Owned Owned (1) Nicholas J. Swenson, AO Partners I, L.P.; and AO Partners, LLC; (2), (4) 5000 West 36 th Street, Suite 200 Minneapolis, MN 55416 1,026,343 30.9 % Raymond E. Cabillot; Farnam Street Partners, L.P.; Farnam Street Capital, Inc.; and Peter O. Haeg (3), (4) 3033 Excelsior Blvd., Suite 560 Minneapolis, MN 55416 364,846 11.0 % Richard L. Van Kirk (4) 116,779 3.5 % Alisha K. Charlton (4) 20,589 * Katrina M.K. Philp (4), (5) 18,696 * Angelita R. Domingo (4) 16,687 * William J. Farrell III (4) 9,100 * David C. Hovda (4) 6,300 * All Directors, Director Nominees and Named Executive Officers as a group (8 persons) (4) 1,579,340 47.5 % ____________

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.